Mr Luke Nicholson

Mr Luke Nicholson is a leading Consultant Ophthalmologist and Medical Retina Specialist with expertise in the diagnosis and treatment of complex retinal diseases. He provides specialist care for patients with diabetic eye disease, diabetic macular oedema, age-related macular degeneration (AMD), retinal vein occlusion, central serous chorioretinopathy and other retinal conditions, as well as cataract surgery.

Mr Nicholson is a Consultant Ophthalmologist at Moorfields Eye Hospital NHS Foundation Trust, one of the world's foremost eye hospitals. He has held several senior leadership positions at Moorfields, including Clinical Lead for the Medical Retina Digital Clinics and Director of the Medical Retina Service. He currently serves as Chief Oculist, overseeing key outpatient and clinical services, and is the Clinical Lead for Retinal Vein Occlusion.

Recognised nationally and internationally for his expertise in retinal disease, Mr Nicholson specialises in the management of retinal vascular disorders and advanced therapies for sight-threatening conditions. He has extensive experience in intravitreal injection treatments, retinal imaging interpretation, and the delivery of personalised treatment strategies designed to preserve and improve vision.

Mr Nicholson graduated with MBBS with Distinction from Newcastle University and subsequently completed specialist ophthalmic training in the United Kingdom, gaining a Certificate of Completion of Training (CCT) in Ophthalmology. He holds a Doctorate in Retinal Vascular Diseases (MD[Res]) from University College London and is a Fellow of the Royal College of Ophthalmologists (FRCOphth). He is also a Fellow of the European Board of Ophthalmology (FEBO) and an active member of EURETINA.

Alongside his clinical practice, Mr Nicholson has an established academic and research career. His research has focused on retinal vein occlusion, diabetic retinopathy and retinal imaging biomarkers, with more than 80 peer-reviewed publications in leading ophthalmic journals. He has led and contributed to several national and international clinical trials, helping to advance treatments for retinal vascular disease and diabetic eye disease.

Patients value Mr Nicholson's clear communication, meticulous attention to detail and commitment to delivering the highest standards of personalised care. He combines the latest evidence-based treatments with a compassionate, patient-centred approach, ensuring that every patient receives expert advice and tailored management of their eye condition.